Vittal Vasista

Insider Reports History

Location
Rockville, MD
Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vittal Vasista:

Company Role Class Num Shares Value Price $ Report Date Ownership
REGENXBIO Inc. Chief Financial Officer Common Stock 246,534 $926,968 $3.76 19 Mar 2024 Direct
REGENXBIO Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 0 19 Mar 2024 Direct

Insider Reports Filed by Vittal Vasista

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGNX REGENXBIO Inc. 19 Mar 2024 2 +$75,354 4 Chief Financial Officer 21 Mar 2024, 17:20
RGNX REGENXBIO Inc. 02 Jan 2024 3 -$81,385 4 Chief Financial Officer 04 Jan 2024, 16:17
RGNX REGENXBIO Inc. 31 May 2023 2 +$29,750 4 Chief Financial Officer 02 Jun 2023, 16:12
RGNX REGENXBIO Inc. 03 Jan 2023 3 -$30,232 4 Chief Financial Officer 05 Jan 2023, 15:06
RGNX REGENXBIO Inc. 30 Aug 2022 1 -$72,573 4 Chief Financial Officer 31 Aug 2022, 18:01
RGNX REGENXBIO Inc. 04 Aug 2022 2 -$622,035 4 Chief Financial Officer 08 Aug 2022, 16:04
RGNX REGENXBIO Inc. 01 Aug 2022 1 -$75,012 4 Chief Financial Officer 03 Aug 2022, 17:26
RGNX REGENXBIO Inc. 13 Jul 2022 2 -$144,028 4 Chief Financial Officer 15 Jul 2022, 16:18
RGNX REGENXBIO Inc. 20 Jan 2022 2 +$25,415 4 Chief Financial Officer 24 Jan 2022, 15:25
RGNX REGENXBIO Inc. 03 Jan 2022 2 $0 4 Chief Financial Officer 04 Jan 2022, 20:07
RGNX REGENXBIO Inc. 27 Jul 2021 2 +$8,500 4 Chief Financial Officer 29 Jul 2021, 16:21